Source: Journal of the american heart association. Unidade: FM
Subjects: CAFEÍNA, DISPNEIA, MORTALIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FURTADO, Remo H. M et al. Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 Trial. Journal of the american heart association, v. 9, n. 10, 2020Tradução . . Disponível em: https://doi.org/10.1161/JAHA.119.015785. Acesso em: 16 ago. 2024.APA
Furtado, R. H. M., Venkateswaran, R. V., Nicolau, J. C., Gurmu, Y., Bhatt, D. L., Storey, R. F., et al. (2020). Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 Trial. Journal of the american heart association, 9( 10). doi:10.1161/JAHA.119.015785NLM
Furtado RHM, Venkateswaran RV, Nicolau JC, Gurmu Y, Bhatt DL, Storey RF, Steg PG, Magnani G, Goto S, Dellborg M. Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 Trial [Internet]. Journal of the american heart association. 2020 ; 9( 10):[citado 2024 ago. 16 ] Available from: https://doi.org/10.1161/JAHA.119.015785Vancouver
Furtado RHM, Venkateswaran RV, Nicolau JC, Gurmu Y, Bhatt DL, Storey RF, Steg PG, Magnani G, Goto S, Dellborg M. Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 Trial [Internet]. Journal of the american heart association. 2020 ; 9( 10):[citado 2024 ago. 16 ] Available from: https://doi.org/10.1161/JAHA.119.015785